삼성서울병원

Ko En

Radiation Oncology Yoo, Gyu Sang M.D

Expertise
Colorectal cancer, genitourinary cancer, sarcoma, rare cancer, benign tumor,
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

2015~2021 Ph.D. in Medicine School of Medicine, Sungkyunkwan University, Korea
2009~2012 Master of Science School of Medicine, Sungkyunkwan University, Korea

Post-Graduate Training

Fellowship   2018~2020 Department of Radiation Oncology, Samsung Medical Center
Residency   2014~2018 Department of Radiation Oncology, Samsung Medical Center
Internship   2013~2014 Samsung Medical Center

Professional Appointments

2022~Present Clinical Instructor Department of Radiation Oncology, Samsung Medical Center

Professional Memberships

2018~Present Member The Korean Society of Radiation Oncology
2019~Present Member The Korean Liver Cancer Association

Selected Publications

  • CLIN ORTHOP SURG 2024 10.4055/cios24158 The Incidence and Risk Factors of Symptomatic Local Recurrence Following Surgical Treatment for Spinal Metastasis with Involvement of All Three Columns: Focusing on the Extent of Tumor Removal Park, JS; Park, SJ; Kang, DH; Lee, CS; Yoo, GS
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.920 The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis Jeong, JU; Rim, CH; Yoo, GS; Cho, WK; Chie, EK; Ahn, YC; Lee, JH
    View PubMed
  • ANTICANCER RES 2024 10.21873/anticanres.17029 Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma Seo, SH; Yu, JI; Park, HC; Yoo, GS; Choi, MS; Rhim, H; Lee, MW; Han, S; Park, B; Shim, JS
    View PubMed
  • CANCER MED-US 2024 10.1002/cam4.7023 A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy Jang, JY; Kim, K; Chen, MF; Akimoto, T; Wang, MLC; Kim, MJ; Kim, K; Lee, TH; Yoo, GS; Park, HC
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2023.479 Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group's Comparative Survey Study Cho, WK; Yoo, GS; Rim, CH; Jeong, JU; Chie, EK; Ahn, YC; Cho, HM; Um, JW; Suh, YG; Chang, AR; Lee, JH
    View PubMed
  • PROSTATE INT 2023 10.1016/j.prnil.2023.07.002 Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Lee, HM; Jeon, SS; Il Seo, S; Jeong, BC; Jeon, HG; Sung, HH; Kang, M; Song, W; Chung, JH; Bae, BK; Park, W
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1599 Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy Yoo, GS; Rim, CH; Cho, WK; Jeong, JU; Chie, EK; Cho, HM; Um, JW; Ahn, YC; Lee, JH
    View PubMed
  • FRONT SURG 2023 10.3389/fsurg.2023.1209698 Effect of pre-operative radiation therapy on surgical outcome in retroperitoneal sarcoma Jo, SJ; Park, SSW; Yoo, GS; Kim, KD; Lim, SH; Kim, J; Kim, MJ; Yu, JI; Park, JB; Lee, KW
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.960527 Clinical implication and management of rectal cancer with clinically suspicious lateral pelvic lymph node metastasis: A radiation oncologist's perspective Yoo, GS; Park, HC; Yu, JI
    View PubMed
  • INT J MOL SCI 2022 10.3390/ijms232112923 Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm Lee, H; Ryu, HS; Park, HC; Yu, JI; Yoo, GS; Choi, C; Nam, H; Lee, JJB; Do, IG; Han, D; Ha, SY
    View PubMed
  • RADIOTHER ONCOL 2022 10.1016/j.radonc.2022.09.003 A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases Kim, K; Il Yu, J; Park, HC; Yoo, GS; Lim, D; Noh, JM; Jeong, WK
    View PubMed
  • CANCERS 2022 10.3390/cancers14194556 The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer Shin, H; Yu, JI; Park, HC; Yoo, GS; Cho, S; Park, JO; Lee, KT; Lee, KH; Lee, JK; Park, JK; Heo, JS; Han, IW; Shin, SH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.332 Chronological Analysis of Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors Yoo, GS; Yu, JI; Cho, S; Han, Y; Oh, Y; Lim, DH; Nam, HR; Lee, JW; Sung, KW; Shin, HJ
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.928119 Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017 Bae, BK; Park, HC; Yu, JI; Yoo, GS; Sinn, DH; Choi, MS; Oh, JH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • CANCERS 2022 10.3390/cancers14092081 The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment Bae, BK; Park, HC; Yoo, GS; Choi, MS; Oh, JH; Yu, JI
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11688-w ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11592-3 Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
    View PubMed
  • CLIN BREAST CANCER 2022 10.1016/j.clbc.2021.06.013 Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study Yoo, GS; Kang, D; Kim, IR; Park, H; Kim, E; Cho, WK; Kim, H; Choi, DH; Ma, JC; Park, W
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1373 Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma Yoo, GS; Park, W; Pyo, H; Jeong, BC; Jeon, HG; Kang, M; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, BK; Kim, CK; Park, SY; Kwon, GY
    View PubMed
  • CANCERS 2022 10.3390/cancers14010040 Feasibility of Synthetic Computed Tomography Images Generated from Magnetic Resonance Imaging Scans Using Various Deep Learning Methods in the Planning of Radiation Therapy for Prostate Cancer Yoo, GS; Luu, HM; Kim, H; Park, W; Pyo, H; Han, Y; Park, JY; Park, SH
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2021.409 Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea Lee, SU; Yang, K; Moon, SH; Suh, YG; Yoo, GS
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2021.066 Physical and Biological Characteristics of Particle Therapy for Oncologists Byun, HK; Han, MC; Yang, K; Kim, JS; Yoo, GS; Koom, WS; Kim, YB
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90065-1 Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • CLIN MOL HEPATOL 2021 10.3350/cmh.2020.0095 Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study Yoo1, GS; Ahn, WG; Kim, SY; Kang, W; Choi, C; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e66 Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence Baek1, JY; Choi, DH; Park, W; Kim, H; Cho, WK; Yoo, GS
    View PubMed
  • CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02794-3 Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab Kim1, N; Yu, JI; Park, HC; Yoo, GS; Choi, C; Hong, JY; Lim, HY; Lee, J; Choi, MS; Lee, JE; Kim, K
    View PubMed
  • CANCERS 2020 10.3390/cancers12092395 Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter? Yoo1, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY
    View PubMed
  • INT J COLORECTAL DIS 2020 10.1007/s00384-020-03701-z Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin Baek1, JY; Yu, JI; Park, HC; Choi, DH; Yoo, GS; Lee, WY; Yun, SH; Cho, YB; Park, YA; Kim, HC; Nam, H
    View PubMed
  • CANCERS 2020 10.3390/cancers12051300 Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed